Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Begum Kayar is active.

Publication


Featured researches published by Begum Kayar.


Journal of Clinical and Experimental Dentistry | 2012

Polymerase chain reaction of enterococcus faecalis and candida albicans in apical periodontitis from Turkish patients

Aysin Dumani; Oguz Yoldas; Sehnaz Yilmaz; Fatih Köksal; Begum Kayar; Beril Akcimen; Gulsah Seydaoglu

Aim: The aim of this study was to determine the frequency of two important pathogenic microorganisms associated with endodontic infections, Enterococcus faecalis and Candida albicans, in root canal samples from patients with necrotic pulps or failed canal therapy by polymerase chain reaction method. Method: Microbial samples were obtained from 117 teeth with necrotic pulp tissues and 114 teeth with failed endodontic treatment. Results: E.faecalis were identified in 16% of the necrotic and 10% of the retreated root canal infections by PCR. C.albicans genome were identified in 20% and 11% of the necrotic and retreated root canal infections, respectively, by PCR. The frequencies of microbiota were not statistically different between necrotic and retreatment groups (p > 0.05, chi squared test). Conclusions: PCR analysis of teeth with periapical lesions revealed that E.faecalis was found in fewer patients than in previous studies. The C.albicans prevelance was consistent with previous reports. No statistical difference was found between primary and secondary root canal infections for C.albicans or E.faecalis. Key words:Primary root canal infection, secondary root canal infection, E.faecalis, C.albicans.


Biomedicine & Pharmacotherapy | 2017

New drugs for the treatment of Mycobacterium tuberculosis infection

Manaf AlMatar; Husam AlMandeal; Işıl Var; Begum Kayar; Fatih Köksal

Tuberculosis presents a grave challenge to health, globally instigating 1.5 million mortalities each year. Following the breakthrough of first-line anti-TB medication, the number of mortalities reduced greatly; nonetheless, the swift appearance of tuberculosis which was drug-resistant, as well as the capability of the bacterium to survive and stay dormant are a considerable problem for public health. In order to address this issue, several novel possible candidates for tuberculosis therapy have been subjected to clinical trials of late. The novel antimycobacterial agents are acquired from different categories of medications, operate through a range of action systems, and are at various phases of advancement. We therefore talk about the present methods of treating tuberculosis and novel anti-TB agents with their action method, in order to advance awareness of these new compounds and medications.


Pharmacological Research | 2017

Antimicrobial peptides as an alternative to anti-tuberculosis drugs

Manaf AlMatar; Essam A. Makky; Gülfer Yakıcı; Işıl Var; Begum Kayar; Fatih Köksal

Tuberculosis (TB) presently accounts for high global mortality and morbidity rates, despite the introduction four decades ago of the affordable and efficient four-drugs (isoniazid, rifampicin, pyrazinamide and ethambutol). Thus, a strong need exists for new drugs with special structures and uncommon modes of action to effectively overcome M. tuberculosis. Within this scope, antimicrobial peptides (AMPs), which are small, cationic and amphipathic peptides that comprise a section of the innate immune system, are currently the leading potential agents for the treatment of TB. Many studies have recently illustrated the capability of anti-mycobacterial peptides to disrupt the normal mycobacterial cell wall function through various modes, thereby interacting with the intracellular targets, as well as encompassing nucleic acids, enzymes and organelles. This review presents a wide array of antimicrobial activities, alongside the associated properties of the AMPs that could be utilized as potential agents in therapeutic tactics for TB treatment.


Current Microbiology | 2017

Are There Any Other Compounds Isolated From Dermacoccus spp at All

Manaf AlMatar; Mohamed A. Eldeeb; Essam A. Makky; Fatih Köksal; Işıl Var; Begum Kayar

Microbial-derived natural products have functional and structural diversity and complexity. For several decades, they have provided the basic foundation for most drugs available to modern medicine. Microbial-derived natural products have wide-ranging applications, especially as chemotherapeutics for various diseases and disorders. By exploring distinct microorganisms in different environments, small novel bioactive molecules with unique functionalities and biological or biomedical significance can be identified. Aquatic environments, such as oceans or seas, are considered to be sources of abundant novel bioactive compounds. Studies on marine microorganisms have revealed that several bioactive compounds extracted from marine algae and invertebrates are eventually generated by their associated bacteria. These findings have prompted intense research interest in discovering novel compounds from marine microorganisms. Natural products derived from Dermacoccus exhibit antibacterial, antitumor, antifungal, antioxidant, antiviral, antiparasitic, and eventually immunosuppressive bioactivities. In this review, we discussed the diversity of secondary metabolites generated by genus Dermacoccus with respect to their chemical structure, biological activity, and origin. This brief review highlights and showcases the pivotal importance of Dermacoccus-derived natural products and sheds light on the potential venues of discovery of new bioactive compounds from marine microorganisms.Graphical Abstract


Pharmacological Reports | 2017

Novel compounds targeting InhA for TB therapy

Manaf AlMatar; Essam A. Makky; Işıl Var; Begum Kayar; Fatih Köksal

Tuberculosis (TB) is described as lethal disease in the world. Resistant to TB drugs is the main reason to have unfavourable outcomes in the treatment of TB. Therefore, new agents to replace existing drugs are urgently needed. Previous reports suggested that InhA inhibitors, an enoyl-ACP-reductase, might provide auspicious candidates which can be developed into novel antitubercular agents. In this review, we explain the role of InhA in the resistance of isoniazid. Furthermore, five classes of InhA inhibitors, which display novel binding modes and deliver evidence of their prosperous target engagement, have been debated.


Current Drug Metabolism | 2017

The physiological/pathophysiological significance of Vitamin D in cancer, cardiovascular disorders and beyond.

Manaf AlMatar; Husam AlMandeal; Essam A. Makky; Begum Kayar; Emel Yarar; Işıl Var; Fatih Köksal

BACKGROUND Vitamin D, a molecular precursor of the potent steroid hormone calcitriol, has crucial functions and roles in physiology and pathophysiology. Tellingly, calcitriol has been shown to regulate various cellular signalling networks and cascades that have crucial role in cancer biology and diagnostics. Mounting lines of evidences from previous clinical and preclinical investigations indicate that the deficiency of vitamin D may contribute to the carcinogenesis risk. Concomitantly, recent reports suggested that significant reduction in the cancer occurrence and progression is more likely to appear after vitamin D supplementation. Furthermore, a pivotal role functioned by vitamin D in cardiovascular physiology indicates that the deficiency of vitamin D is significantly correlated with enhanced prevalence of stroke, hypertension and myocardial infarction. Notably, vitamin D status is more likely to be used as a lifestyle biomarker, since poor and unhealthy lifestyles are correlated with the deficiency of vitamin D, a feature which may result in cardiovascular complications. Moreover, recent reports revealed that the effect of vitamin D is to cover not only cardiovascular system but also skeletal system. OBJECTIVE Herein, we are highlighting the recent knowledge of vitamin D roles and functions with respect to pathophysiological disorders such as cancer, cardiovascular diseases, rheumatoid arthritis (RA) and debate the potential avails of vitamin D on slowing cancer, cardiovascular disease and RA progression. CONCLUSION The findings of this review confirm that the importance of vitamin D metabolites or analogues which can provide a helpful platform to target some kinds of cancer, particularly when used in combination with existing therapies. Moreover, the correlation between vitamin D deficiencies with cardiovascular diseases and rheumatoid arthritis (RA) progression might suggest a pivotal role of vitamin D in either initiation or progression of these diseases.


Kafkas Universitesi Veteriner Fakultesi Dergisi | 2015

Türkiye’de Sığırlardan İzole Edilen M. tuberculosis Suşlarının Spoligotiplendirmesi

Nevin Tuzcu; Begum Kayar; Elif Bilge Uysal; Yasin Gülcü; Mehdi Marzi; Fatih Köksal

Although it is generally accepted that M.bovis leads to tuberculosis in cattle, there are statements given from the different regions of the world, referring to the fact that M. tuberculosis, which is known as the human tuberculosis agent, causes tuberculosis in cattle as well. The material of the study consisted of 13 M. tuberculosis isolates which were isolated and identified from the organ pieces of 95 cattle with the culture methods; these organ pieces had been taken from the cattle with granulomatous lesion detection after the slaughtering in slaughterhouses located in Çukurova region and brought to the laboratory under sterile conditions. It was determined in the genotyping conducted by using the Spoligotyping method that 13 of the 55 isolates were M. tuberculosis and they belonged to the T1 family (SIT53) by becoming dense in one cluster (100%). Consequently, it was shown with this study that M. tuberculosis, which leads to tuberculosis in humans, could be transmitted from humans to animals and from animals to humans again, and researching the human and epidemiological tuberculosis cases by using molecular epidemiology-based methods such as spoligotyping might provide useful information about explaining the ways of transmission of tuberculosis.


Diagnostic Microbiology and Infectious Disease | 2005

Rapid diagnosis and genotyping of Leishmania isolates from cutaneous and visceral leishmaniasis by microcapillary cultivation and polymerase chain reaction–restriction fragment length polymorphism of miniexon region

Mehmet Sami Serin; Kenan Dağlıoğlu; Melahat Bagirova; Adil M. Allahverdiyev; Soner Uzun; Zeynep Vural; Begum Kayar; Seda Tezcan; Mesut Yetkin; Gönül Aslan; Gurol Emekdas; Fatih Köksal


Diagnostic Microbiology and Infectious Disease | 2007

Consistence of miniexon polymerase chain reaction-restriction fragment length polymorphism and single-copy gene sequence analyses in discriminating Leishmania genotypes

Mehmet Sami Serin; Kayoko Waki; Kwang-Poo Chang; Gönül Aslan; Sahin Direkel; Feza Otag; Begum Kayar; Fatih Köksal; Gurol Emekdas


Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology | 2007

Disinfection of artificially contaminated Resilon cones with chlorhexidine and sodium hypochlorite at different time exposures

Aysin Dumani; Oguz Yoldas; A.Sehnaz Isçi; Fatih Köksal; Begum Kayar; Esra Polat

Collaboration


Dive into the Begum Kayar's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Essam A. Makky

Universiti Malaysia Pahang

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge